Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
about
The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential ThrombocythemiaIdentification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.Anagrelide and Mutational Status in Essential Thrombocythemia.Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.
P2860
Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@en
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@nl
type
label
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@en
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@nl
prefLabel
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@en
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@nl
P2093
P2860
P356
P1476
Anagrelide platelet-lowering e ...... ght into potential mechanisms.
@en
P2093
A C Glembotsky
F C Molinas
M Grodzielski
N P Goette
P G Heller
Y R Espasandin
P2860
P304
P356
10.1111/JTH.12850
P577
2015-02-18T00:00:00Z